Literature DB >> 2677826

Pituitary microadenomas. Does Gadolinium enhance their demonstration?

P Macpherson1, D M Hadley, E Teasdale, G Teasdale.   

Abstract

Ten patients with biochemical evidence of a hormonally active pituitary adenoma were examined by dynamic contrast enhanced computed tomography (CT) and then by pre and post Gadolinium-DTPA (Gd-DTPA) enhanced magnetic resonance imaging (MRI). Excluding one false positive case, CT and unenhanced MRI were comparable in the detection of microadenoma. Post Gd-DTPA examination gave more clear evidence of the actual adenoma in two patients and aided in the demonstration of a third. However, in two others all imaging techniques failed to demonstrate the microadenoma subsequently found at surgery. On the post enhancement MRI it was easier to assess the relationship of a tumour to the cavernous sinus and to visualise the relationships of the parasellar carotid arteries.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677826     DOI: 10.1007/bf00344169

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  9 in total

1.  MR imaging of pituitary adenoma: CT, clinical, and surgical correlation.

Authors:  P C Davis; J C Hoffman; T Spencer; G T Tindall; I F Braun
Journal:  AJR Am J Roentgenol       Date:  1987-04       Impact factor: 3.959

2.  MR imaging of prolactin-secreting microadenomas.

Authors:  K W Pojunas; D L Daniels; A L Williams; V M Haughton
Journal:  AJNR Am J Neuroradiol       Date:  1986 Mar-Apr       Impact factor: 3.825

3.  Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.

Authors:  P C Davis; J C Hoffman; J A Malko; G T Tindall; Y Takei; L Avruch; I F Braun
Journal:  AJNR Am J Neuroradiol       Date:  1987 Sep-Oct       Impact factor: 3.825

4.  MR imaging of cavernous sinus involvement by pituitary adenomas.

Authors:  G Scotti; C Y Yu; W P Dillon; D Norman; N Colombo; T H Newton; J De Groot; C B Wilson
Journal:  AJR Am J Roentgenol       Date:  1988-10       Impact factor: 3.959

5.  Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland.

Authors:  J L Doppman; J A Frank; A J Dwyer; E H Oldfield; D L Miller; L K Nieman; G P Chrousos; G B Cutler; D L Loriaux
Journal:  J Comput Assist Tomogr       Date:  1988 Sep-Oct       Impact factor: 1.826

6.  Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.

Authors:  A J Dwyer; J A Frank; J L Doppman; E H Oldfield; A M Hickey; G B Cutler; D L Loriaux; T F Schiable
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

7.  Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA.

Authors:  D P Kilgore; R K Breger; D L Daniels; K W Pojunas; A L Williams; V M Haughton
Journal:  Radiology       Date:  1986-09       Impact factor: 11.105

8.  High-resolution computed tomography in pituitary microadenoma: is seeing believing?

Authors:  E Teasdale; G Teasdale; F Mohsen; P Macpherson
Journal:  Clin Radiol       Date:  1986-05       Impact factor: 2.350

9.  1.5-T MR imaging of pituitary microadenomas: technical considerations and CT correlation.

Authors:  M V Kulkarni; K F Lee; C B McArdle; J W Yeakley; F L Haar
Journal:  AJNR Am J Neuroradiol       Date:  1988 Jan-Feb       Impact factor: 3.825

  9 in total
  3 in total

1.  Gadolinium DTPA enhanced magnetic resonance imaging in acute head injury.

Authors:  D A Lang; D M Hadley; G M Teasdale; P Macpherson; E Teasdale
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 2.  Neuroendocrine imaging.

Authors:  D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-03       Impact factor: 3.825

3.  Cavernous sinus meningioma presenting as orbital apex syndrome. Diagnostic methods of dynamic MRI, spoiled GRASS (SPGR) image.

Authors:  F Ikawa; T Uozumi; K Kiya; K Arita; K Kurisu; K Harada
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.